Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?

Table 3

Multivariate prediction of cognitive domain scores in persons with CIS and eRRMS ().

Measure	Predictors	Partial -square	Model -square
Power of Attention	MSSES-Total	0.4011	0.4011
	Age	0.0500	0.4511
Continuity of Attention	MSSES-Function	0.2245	0.2245
	Age	0.0633	0.2878
Cognitive Reaction Time	MSSES-Control	0.1566	0.1566
	MFIS-5	0.2216	0.3782
	BDI	0.1127	0.4910
	Age	0.1422	0.6332
Reaction Time Variability	MSSES-Total	0.3372	0.3372
Working Memory	Gender	0.1745	0.1745
	MSIS-29	0.1477	0.3223
	Age	0.1284	0.4507
	MSSES-Total	0.0525	0.5031
Episodic Memory	MSSES-Function	0.2109	0.2109
	EDSS	0.1442	0.3551
Speed of Memory	MSSES-Total	0.4011	0.4011
	Age	0.0500	0.4511

CIS, Clinically Isolated Syndrome; eRRMS, early Relapsing Remitting multiple sclerosis; MSSES, Multiple Sclerosis Self-Efficacy Scale; MFIS-5, Modified Fatigue Impact Scale 5-Item Version; BDI, Beck Depression Inventory; MSIS-29, Multiple Sclerosis Impact Scale-29; EDSS, Expanded Disability Status Scale.